GlassScriptPhysician profile
Rodolfo Martinez
NPI 1831168442
$878.28
in general payments reported to CMS, 2019-2025
12 companies · $26.28 in 2025
The $26.28 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $409 · 2021: $14.56 · 2022: $79.77 · 2023: $122 · 2025: $26.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $316.92 | 2019-2021 | |
| Depuy Synthes Sales INC. | $125.00 | 2020 | |
| Biotissue Holdings INC. | $122.29 | 2023 | |
| Intuitive Surgical, INC. | $118.19 | 2019 | |
| Smith+Nephew, INC. | $40.66 | 2019 | |
| Braintree Laboratories, INC. | $33.72 | 2022 | |
| Integra Lifesciences Corporation | $31.41 | 2022 | |
| Array Biopharma INC | $26.28 | 2025 | Mektovi, Xalkori, Braftovi |
| Axonics, INC. | $20.82 | 2020 | |
| Rigel Pharmaceuticals, INC. | $15.27 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.64 | 2022 | |
| Amniox Medical, INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodolfo Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.